"Arcos Dorados renews master franchise agreement with McDonald’s" was originally created and published by Verdict Food ...

One prominent FDA-watcher said he sees no new regulations coming down in a new Trump administration, but he wondered if this was an opportunity to further reorganize food safety, possibly with a ...

Overall EV sales gained 12%, pushing the full-year total to a record 1.3 million, according to forecasts from researcher Cox Automotive.

The threat by President-elect Donald Trump to end tax credits for electric vehicles helped lift sales in the fourth quarter, giving U.S. automakers a much-needed boost after a disappointing year.

Immuno-oncology (IO) drugs or cancer therapeutics represent one of the most promising areas of medical innovation in the next five years, according to a report on Friday. The report by GlobalData, a ...

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

The “Instrument and Electrical Reliability Engineering (I&E RE)” position in Chevron’s ENGINE Centre (located in Bengaluru, ...

Prasanth Katam, an insurance analyst at GlobalData, noted that South Korea’s economy grew by only 1.4% in 2023, which ...

The surge in tunnelling and anchoring machinery patents is driven by the need for technological innovation to improve mining processes.

According to key opinion leaders, positive SURMOUNT-5 results, alongside Lilly’s business strategy, means Zepbound will overtake competitors.

Eli Lilly's Zepbound is challenging Wegovy in the obesity market, while U.S. health care costs are set to rise 9% in 2025, driven by specialty drugs and inflation.

Eli Lilly and Novo Nordisk have been competing in the obesity market for the past year, making it an opportune time to review the benefits of the two most prominent obesity medications.